Auditory Neuropathy Spectrum Disorder
Symptoms, Doctors, Treatments, Advances & More

Auditory Neuropathy Spectrum Disorder Overview

Save information for later
Sign Up

Learn About Auditory Neuropathy Spectrum Disorder

What is the definition of Auditory Neuropathy Spectrum Disorder?
Auditory neuropathy spectrum disorder (ANSD) is a rare condition that can affect a person's ability to hear. Although sounds enter the inner ear normally, signals from the inner ear to the brain are not transmitted properly. As a result, the condition may be associated with mild to severe hearing loss and poor speech-perception abilities (difficulty understanding speech clearly). ANSD can be associated with other neurological disorders such as Friedrich ataxia, Stevens-Johnson syndrome, Ehlers-Danlos syndrome, and Charcot-Marie-Tooth syndrome. The exact underlying cause of ANSD is not completely understood. In many cases, ANSD occurs in people with no family history of the condition. However, the condition does run in some families suggesting that genetic factors may play a role in some cases.
What are the alternative names for Auditory Neuropathy Spectrum Disorder?
  • Auditory neuropathy spectrum disorder
  • ANSD
  • Auditory dys-synchrony
  • Auditory dyssynchrony
  • Auditory neuropathy
Who are the top Auditory Neuropathy Spectrum Disorder Local Doctors?
Advanced in Auditory Neuropathy Spectrum Disorder
Dr. Johnathan M. Winstead
Otolaryngology
Advanced in Auditory Neuropathy Spectrum Disorder
Dr. Johnathan M. Winstead
Otolaryngology

Ear, Nose And Throat Associates P.C.

2340 Knob Creek Rd, Ste 704, 
Johnson City, TN 
423-929-9101
Languages Spoken:
English
See accepted insurances

. Dr. Winstead is rated as an Advanced provider by MediFind in the treatment of Auditory Neuropathy Spectrum Disorder. He is also highly rated in 30 other conditions, according to our data. His clinical expertise encompasses Nasal Septal Hematoma, Low Nasal Bridge, White Sponge Nevus, and Perichondritis. Dr. Winstead is board certified in American Board Of Otolaryngology.

Elite in Auditory Neuropathy Spectrum Disorder
Doris-eva E. Bamiou
Elite in Auditory Neuropathy Spectrum Disorder
Doris-eva E. Bamiou
149 Tottenham Court Road, W1T 7DN, 
London, ENG, GB 

Doris-eva Bamiou practices practicing medicine in London, United Kingdom. Bamiou is rated as an Elite expert by MediFind in the treatment of Auditory Neuropathy Spectrum Disorder. They are also highly rated in 6 other conditions, according to our data. Their clinical expertise encompasses Auditory Processing Disorder, Auditory Neuropathy Spectrum Disorder, Siderosis, and Hearing Loss.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Auditory Neuropathy Spectrum Disorder
Prudence S. Allen
Elite in Auditory Neuropathy Spectrum Disorder
Prudence S. Allen
London, ON, CA 

Prudence Allen practices practicing medicine in London, Canada. Ms. Allen is rated as an Elite expert by MediFind in the treatment of Auditory Neuropathy Spectrum Disorder. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Auditory Neuropathy Spectrum Disorder, Auditory Processing Disorder, and Hearing Loss.

View All Doctors
What are the latest Auditory Neuropathy Spectrum Disorder Clinical Trials?
Contribution of Central Auditory Processing Disorder (CAPD) to Sleep Disturbances in Autism Spectrum Disorder (ASD)
Contribution of Central Auditory Processing Disorder (CAPD) to Sleep Disturbances in Autism Spectrum Disorder (ASD)
Enrollment Status: Recruiting
Publish Date: February 04, 2026

Summary: The proposed study aims to understand poor sleep as a possible cause to CAPD in children and adolescents with ASD (ASD+) compared to ASD youth without CAPD (ASD-), using both caregiver-report and objective clinician administered measures. Additionally, the study will aim to understand the complex relationship between CAPD, sleep, and other associated phenotypic features of ASD such as executive an...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Double-Blinded, Placebo-Controlled, Randomized, Phase 1/2a Clinical Study to Test the Safety and Efficacy of a Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
A Double-Blinded, Placebo-Controlled, Randomized, Phase 1/2a Clinical Study to Test the Safety and Efficacy of a Treatment for a Form of Age-Related Central Auditory Processing Disorder Consisting of Clemastine Fumarate Plus Engineered Sound
Enrollment Status: Recruiting
Publish Date: December 26, 2025
Intervention Type: Combination product, Drug
Study Phase: Phase 1/Phase 2

Summary: The goal of this clinical trial is to determine the efficacy of Clemastine Fumarate in the presence of engineered sound to treat age-related central auditory processing disorder (CAPD). This disorder impacts 800M patients worldwide, including \ 1/3 people over 40 years of age and \ 1/2 people over 65, resulting in an inability to hear in noisy environments. The primary hypothesis this study aims t...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center